跳至主要内容
临床试验/CTRI/2020/09/028087
CTRI/2020/09/028087尚未招募不适用

Evaluation of HRCT chest manifestation in COVID 19 patients with pre-existing comorbidity.

KIMS Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2020年10月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
KIMS Hospital
入组人数
500
试验地点
1
主要终点
To assess the degree of severity of HRCT chest manifestation in COVID patients with pre-existing comorbidity.

研究概览

简要总结

COVID 19(corona virus disease) is a rapidly spreading, contagious infection caused bynovel corona virus predominantly affecting the respiratory system. It hasbecome a global pandemic.1 There are various research works beingdone presently all over the world for understanding the pathogenesis, clinical,biochemical, radiological manifestations of the disease, so that propermanagement can be achieved. Patients suffering from COVID19 having pre-existingcomorbidities or of elderly age group have shown worse prognosis.2 CThas high accuracy for the diagnosis of COVID 19 by revealing the features ofviral pneumonia and hence helpful in early diagnosis and proper patientmanagement and follow up.3 In this study we want to focus on theHRCT chest findings of COVID 19 patients with pre-existing comorbidities.

研究设计

研究类型
Observational

入排标准

年龄范围
6.00 Year(s) 至 90.00 Year(s)(—)
性别
All

入选标准

  • All the COVID positive patients admitted to Odisha COVID hospital, KIMS.
  • with positive HRCT chest features.

排除标准

  • Patients who have not undertaken RT-PCR and HRCT thorax.

结局指标

主要结局

To assess the degree of severity of HRCT chest manifestation in COVID patients with pre-existing comorbidity.

时间窗: Baseline

次要结局

  • To correlate the clinical severity with CT severity(Baseline)

研究者

发起方
KIMS Hospital
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验